Financial developments in 2013

The total expenditure of MSF amounted to €188.3 million in 2013. We spent €151.9 million on our own aid projects, €10.9 million more than in 2012. This money primarily went towards emergency aid in the Central African Republic, the Democratic Republic of the Congo, Myanmar and South Sudan.

Our total income in 2013 amounted to €202.4 million. This was €26.2 million more than we budgeted. The public supported us generously for our work in South Sudan, the Central African Republic and Syria and our emergency aid campaign in the Philippines. In addition to our own projects, we also financed MSF-Spain’s aid to the amount of €7.7 million. We cooperated intensively with this MSF section in 2013 in, among others, the Central African Republic and South Sudan.

Unforeseen income increase

While our expenditure of €188.3 million exceeded our budget by about 4%, we closed the 2013 financial year with an unforeseen income increase thanks to our own fundraising activities in the Netherlands and the activities of other MSF sections. It was assumed until well into 2013 that the income target would not be met. The increase in income was only revealed during the last 2 months of that year. This increase was related to the emergency medical aid we provided in the Central African Republic, South Sudan and Syria and the emergency aid provided in the Philippines, and the media attention these projects received.

For insight into the expenditure per project country, see projects.

For a comprehensive overview of financial developments, see our Financial Statements.

 

Our expenditure in 2013

The total expenditure amounted to €188.3 million; €7.1 million more than budgeted. In 2013, MSF spent €151.9 million on its own aid projects, €10.9 million more than in 2012.

Niet weg gooien

In addition to our own projects, we also financed the aid provided by MSF-Spain to the amount of €7.7 million. We cooperated intensively with this MSF sister organization in 2013 in, among others, the Central African Republic and South Sudan. This helped increase the impact of the aid for the people of these countries considerably.

The office in Amsterdam spent €12.3 million on project support activities (2012: €12.0 million). This amount was primarily spent on medical advice and policy, purchasing of medicines and aid supplies, the recruitment of field staff and the coordination of our projects.

We spent €3.4 million on management and administration (2012: €3.3 million) and we paid €0.8 million in contributions to the international office. Combined this amounted to 2.2% of the total expenditure.

€2.6 million was spent on communication and awareness raising.

We spent a total of €8.2 million on fundraising activities (2012: €7.5 million). This amounted to 4.3% of the total expenditure. €7.5 million of this amount was spent on our own fundraising activities, €0.5 million was spent on the fundraising activities of third parties (including Tour for Life) and €0.2 million went to costs for acquiring funds from our institutional donors; see also Fundraising.

Finally, we spent €1.4 million on our office in India (MSF-India) that was established in 2013.

Our income in 2013

The total income of MSF amounted to €202.4 million in 2013. This was €26.2 million more than the €176.2 million that was budgeted. The sources of our income remained virtually unchanged in 2013. These sources were:

  • €48.4 million from our Dutch donors (2012: €43.7 million), see also Fundraising; and
  • €1.2 million from the fundraising activities of Tour for Life [LINK Tourforlife.nl] , organised by the Emo Foundation (2012: €1.5 million);
  • €13.8 million from the Dutch Postcode Lottery (2012: € 13.5 million). Alongside the regular annual contribution from the Dutch Postcode Lottery of €13.8 million, in 2013 we also received an amount of €6.8 million from their ‘Dream Fund’ for our project for improving the treatment of multidrug-resistant tuberculosis (MDR-TB). The revenues from all these sources are booked in the year that these are spent. In 2013, this concerned an amount of €0.3 million;
  • €1.7 million in interest income (2012: €1.6 million);
  • €111.0 million via donors of the countries in which other MSF sections are active (2012: €91.3 million). We received €78.2 million from our most important partners, above €18.0 million more than expected. The income of our partners also increased unexpectedly at the end of the year;
  • €26.3 million (2012: €20.6 million) in project subsidies from institutional donors (such as the emergency aid funds of foreign governments and the European Union).

We also received an amount of some €2.0 million in donations in kind in 2013. The most important of these donations concerned medicines and food.

The difference between our expenditure and income in 2013

Mainly due to the unforeseen income in November and December, we ended the book year with a surplus of €12.3 million where we had budgeted for a deficit of €4.7 million. The surplus has been added to the reserves. Most of the surplus will be spent in 2014 on projects of MSF-Spain and MSF-France, as part of financial agreements that were made and that apply for the 2012-2015 period.

Exchange rate differences

As we work with many different currencies, exchange rate differences also apply. In 2013, we booked exchange rate losses of €1.7 million (2012: exchange rate profit of €0.9 million). This was mainly due to the fluctuation of the Canadian dollar.